种族差异对 Graves 病甲状腺切除术患者合并症的影响：一项 ACS-NSQIP 分析。
Racial disparities in comorbid conditions among patients undergoing thyroidectomy for Graves' disease: An ACS-NSQIP analysis.
机构信息
Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA, 200 Hawkins Drive, 1500 JCP, Iowa City, IA, 52242, USA.
Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA, 200 Hawkins Drive, 1500 JCP, Iowa City, IA, 52242, USA.
出版信息
Am J Surg. 2021 Jan;221(1):106-110. doi: 10.1016/j.amjsurg.2020.05.023. Epub 2020 May 21.
BACKGROUND
Studies indicate that racial disparities exist in the presentation and outcomes of patients undergoing thyroidectomy for cancer and benign disease. We examined the relationship between race, pre-operative characteristics and outcomes in patients undergoing thyroidectomy for GD.
METHODS
Patients were identified from the 2013-2016 American College of Surgeons NSQIP database using ICD-9/10 codes consistent with diffuse toxic goiter.
RESULTS
AA patients were more likely to have an ASA classification of ≥3 (41% vs 30%, p < 0.001), a higher rate of CHF (2.1% vs 0.5%, p = 0.01), hypertension (46% vs 32%, p < 0.001) and dyspnea (10% vs 5%, p < 0.001) compared to Non-Hispanic Caucasians (NH-C) patients. Complications were higher in patients with ASA≥3 and CHF but not affected by race.
CONCLUSIONS
Analysis of a national database of thyroidectomy for GD revealed a higher burden of preoperative comorbidities in AA patients compared to other races, although race was not an independent predictor of outcomes.
背景
研究表明，癌症和良性疾病患者行甲状腺切除术时存在种族差异表现和结果。我们研究了种族、术前特征与 GD 患者行甲状腺切除术结局之间的关系。
方法
使用符合弥漫性毒性甲状腺肿的 ICD-9/10 编码，从 2013 年至 2016 年美国外科医师学会 NSQIP 数据库中确定患者。
结果
非裔美国人（AA）患者的 ASA 分级≥3 的比例（41% vs 30%，p < 0.001）、充血性心力衰竭（CHF）（2.1% vs 0.5%，p = 0.01）、高血压（46% vs 32%，p < 0.001）和呼吸困难（10% vs 5%，p < 0.001）的发生率均高于非西班牙裔白种人（NH-C）患者。ASA≥3 和 CHF 的患者并发症发生率更高，但不受种族影响。
结论
对 GD 患者甲状腺切除术的国家数据库进行分析显示，AA 患者术前合并症负担高于其他种族，尽管种族不是结局的独立预测因素。
Zotero 插件